Tirzepatide Txauyog ib qho tshuaj tshiab tsim los ntawm Tirzepatide. Tilpolide yog lub ntiaj teb thawj cov piam thaj nyob ntawm insulin stimulating polypeptide (GIP) thiab glucagon zoo li peptide-1 (GLP-1) dual receptor agonist tsim los ntawm Lilly. Tam sim no, nws yog tsuas yog siv nyob rau hauv daim ntawv ntawm kev txhaj tshuaj subcutaneous (xws li Mounjaro thiab Zepbound) los kho hom 2 mob ntshav qab zib thiab rog. Thaum Tirzepatide Spray lub hom phiaj kom ua tiav kev nqus sai thiab yooj yim tswj cov tshuaj los ntawm cov kab mob hauv lub cev (xws li tshuaj tsuag qhov ncauj lossis qhov ntswg), yog li kov yeej cov kev txwv ntawm cov tshuaj txhaj tshuaj. Nyob rau hauv xyoo tas los no, mucosal tshuaj xa cov tshuab tau ua kom muaj kev vam meej hauv kev xa tshuaj, tshwj xeeb tshaj yog nrog kev siv nanotechnology thiab microfluidics, ua rau mucosal nqus ntawm cov tshuaj molecule loj xws li peptides thiab proteins ua tau. Raws li ib tug loj molecule dual receptor agonist, kev tshawb fawb ntawm mucosal xa ntawm tilpotide tau dhau los ua lub ntsiab lus kub. Cov kab mob sib kis ntawm cov kab mob metabolic (xws li ntshav qab zib thiab rog rog) thiab kev puas siab puas ntsws (xws li kev ntxhov siab thiab kev nyuaj siab) yog siab, thiab cov kev kho mob ib txwm tsis tuaj yeem ua tau raws li cov kev xav tau ntawm kev tswj hwm metabolic thiab kev txhim kho kev xav tib lub sijhawm. Tilpotide nthuav tawm muaj peev xwm tiv thaiv kev ntxhov siab thiab tiv thaiv kev nyuaj siab los ntawm kev tswj ob txoj kev ntawm lub plab lub hlwb axis thiab HPA axis. Lub tshuab xa tshuaj mucosal tuaj yeem ua kom zoo dua qhov no, ua tiav kev tswj hwm ntawm cov metabolism thiab kev xav los ntawm qhov pib sai thiab nkag mus hauv nruab nrab.
Peb cov khoom
Tirzepatide COA
Lub physiological mechanism thiab tus nqi txwv cov txheej txheem ntawm lub ntsws nqus ntawm Tirzepatide Spray
Tirzepatide Txau, raws li lub tswv yim tshiab GLP-1/GIP dual lub hom phiaj agonist, nthuav tawm cov txiaj ntsig zoo hauv kev txo qis qab los noj mov, nce kev siv hluav taws xob, txhim kho cov ntshav qabzib, thiab tswj qhov hnyav los ntawm kev ua kom lub GLP-1 thiab GIP receptor signaling pathways. Nws qhov tshwj xeeb dual activation mechanism qhia tau hais tias muaj peev xwm zoo hauv kev kho mob ntshav qab zib hom 2 thiab rog rog. Tam sim no, Tirzepatide feem ntau yog siv los ntawm kev txhaj tshuaj subcutaneous, tab sis muaj teeb meem nrog kev ua raws li tus neeg mob tsis zoo thiab qhov mob hauv zos hauv txoj kev txhaj tshuaj. Pulmonary kev tswj hwm, raws li txoj kev tsis muaj kev cuam tshuam ntawm kev xa tshuaj, muaj qhov zoo xws li bioavailability siab, pib sai, thiab ua raws li tus neeg mob zoo, muab kev xaiv tshiab rau kev xa Tirzepatide.
Lub hauv paus physiological ntawm lub ntsws nqus
Anatomical yam ntxwv ntawm lub ntsws
Lub ntsws yog cov kab mob ua pa tseem ceeb hauv tib neeg lub cev, nrog rau qhov chaw nqus dej loj. Tag nrho cov alveoli hauv cov neeg laus yog kwv yees li 300-400 lab, nrog rau thaj tsam ntawm thaj tsam txog li 100 square metres, uas yog kwv yees li 25 npaug ntawm thaj tsam ntawm lub cev. Lub alveolar phab ntsa yog tsim los ntawm ib txheej ntawm cov epithelial hlwb, thiab cov thickness ntawm cov ntshav cua thaiv tsuas yog hais txog 0.5 micrometers, uas tso cai rau cov tshuaj sai sai nkag mus rau lub alveolar epithelial hlwb thiab nkag mus rau hauv cov hlab ntsha. Tsis tas li ntawd, lub ntsws muaj kev sib txuas ntawm cov hlab ntsha, nrog rau thaj tsam tag nrho ntawm thaj tsam li 90 square meters nyob ib ncig ntawm lub alveoli thiab cov ntshav siab. Tom qab kev nqus tshuaj, nws tuaj yeem nkag mus rau hauv cov kab ke hauv lub cev, tsis txhob cuam tshuam thawj zaug thiab yog li txhim kho bioavailability ntawm cov tshuaj.
Physiological yam ntxwv ntawm lub ntsws
Kev ua haujlwm enzyme hauv lub ntsws yog qhov qis, thiab tus nqi pH nyob ze rau nruab nrab (7.4). Piv nrog rau qhov hnyav acidic ib puag ncig ntawm lub plab zom mov, cov nyhuv degradation ntawm cov tshuaj peptide yog me me. Qhov chaw me me no muab cov txiaj ntsig zoo rau kev nqus cov tshuaj peptide, txo cov tshuaj poob thaum lub sijhawm nqus. Nyob rau tib lub sijhawm, txoj kev tswj hwm tsis yog-txhaj tshuaj tiv thaiv hauv lub ntsws zam qhov mob thiab tsis yooj yim los ntawm kev txhaj tshuaj, txhim kho kev lees paub thiab ua raws li tus neeg mob, thiab tshwj xeeb tshaj yog tsim nyog rau cov neeg mob mob ntev uas yuav tsum tau noj tshuaj ntev -.
Lub physiological mechanism ntawm lub ntsws nqus ntawm Tirzepatide Spray
Deposition ntawm cov tshuaj nyob rau hauv lub ntsws
Tirzepatide TxauTxau tshuaj rau hauv lub ntsws nyob rau hauv daim ntawv ntawm aerosols los yog qhuav hmoov los ntawm ib tug tshwj xeeb inhalation ntaus ntawv. Kev tso tawm ntawm cov tshuaj nyob rau hauv lub ntsws feem ntau cuam tshuam los ntawm cov yam ntxwv xws li aerosol particle loj, nqus pa tawm nrawm, thiab hom ua pa. Feem ntau hais lus, cov tshuaj uas muaj qhov loj ntawm 2-5 microns feem ntau yuav tso rau hauv thaj av alveolar, yog li ua tiav kev nqus tau zoo. Thaum cov neeg mob nqus tau cov tshuaj, cov khoom loj dua tuaj yeem tso rau hauv qhov ua pa sab saud, thaum cov khoom me me tuaj yeem raug tshem tawm los ntawm exhalation. Yog li ntawd, kev tswj xyuas qhov loj ntawm cov khoom siv tshuaj yog qhov tseem ceeb kom ntseeg tau tias cov tshuaj tso tawm hauv lub ntsws zoo.
Dissolution ntawm cov tshuaj nyob rau hauv lub mucus txheej
Tom qab cov tshuaj tso rau hauv lub ntsws, lawv thawj zaug yuav tsum tau yaj hauv cov pa ua pa kom ua tiav cov txheej txheem nqus dej ntxiv. Cov qog ua pa ua pa yog ib qho ntawm cov teeb meem rau kev nqus tshuaj, thiab nws cov viscosity thiab muaj pes tsawg leeg tuaj yeem cuam tshuam rau tus nqi ntawm cov tshuaj. Mucus yog tsim los ntawm dej, mucin, lipids, thiab inorganic ntsev, thiab muaj ib tug tej yam℃ntawm viscoelasticity. Tirzepatide, raws li cov tshuaj peptide, yuav tsum tau kov yeej cov teeb meem cuam tshuam ntawm cov hnoos qeev kom ncav cuag qhov chaw ntawm alveolar epithelial hlwb. Tus nqi ntawm cov tshuaj nyob rau hauv cov hnoos qeev yog nyob ntawm lawv cov physicochemical zog, xws li lipophilicity thiab molecular loj. Cov tshuaj uas muaj lipid solubility ntau dua yuav yaj hauv cov hnoos qeev, yog li ua kom nrawm nrawm dua.
Tshuaj permeation los ntawm alveolar epithelial hlwb
Cov tshuaj molecules yaj nyob rau hauv mucus ces yuav tsum tau nkag mus rau hauv cov hlab ntsha los ntawm alveolar epithelial hlwb. Alveolar epithelial hlwb yog tsim los ntawm hom I thiab hom II alveolar hlwb. Hom I alveolar hlwb yog tiaj tiaj thiab nyias, npog feem ntau ntawm cov alveoli saum npoo thiab ua lub chaw tseem ceeb rau kev sib pauv roj; Hom II alveolar hlwb muaj kev ua haujlwm ntawm kev zais cov surfactants. Cov tshuaj molecules tuaj yeem dhau los ntawm alveolar epithelial hlwb los ntawm kev sib kis, kev thauj mus los, thiab lwm yam. Rau me me molecule peptide tshuaj zoo li Tirzepatide, lawv tsuas yog diffuse passively los ntawm lub cell membrane. Cov lipid solubility, molecular loj, thiab cov nqi ntawm cov tshuaj tuaj yeem cuam tshuam rau lawv lub peev xwm nkag mus rau cov cell membranes. Qhov siab dua lipophilicity, qhov me me ntawm cov molecule, thiab qhov yooj yim dua nws yog rau cov tshuaj tsis siv tshuaj molecules nkag mus rau hauv cov cell membrane.
Nkag mus rau hauv cov hlab ntsha
Tom qab dhau los ntawm alveolar epithelial hlwb, cov tshuaj nkag mus rau hauv capillaries nyob ib ncig ntawm lub alveoli, ces nkag mus rau sab laug atrium los ntawm pulmonary leeg, thiab thaum kawg nkag mus rau hauv lub systemic ncig. Vim muaj cov ntshav txaus hauv lub ntsws, cov tshuaj tuaj yeem xa mus sai sai rau ntau cov ntaub so ntswg thiab cov khoom nruab nrog cev thoob plaws hauv lub cev, ua rau muaj txiaj ntsig zoo. Piv nrog rau kev txhaj tshuaj subcutaneous, kev tswj xyuas pulmonary tuaj yeem ua tiav cov ntshav cov tshuaj muaj txiaj ntsig sai dua, yog li siv cov tshuaj kho mob sai dua. Piv txwv li, hauv kev kho mob ntshav qab zib, lub ntsws siv tshuaj insulin tuaj yeem ncav cuag cov ntshav siab tshaj plaws hauv 7 mus rau 20 feeb, thaum txhaj tshuaj subcutaneous siv sijhawm 30 txog 60 feeb.
Cov yam tseem ceeb cuam tshuam rau lub ntsws nqus ntawm Tirzepatide Spray
Lub physicochemical thaj chaw ntawm cov tshuaj, xws li lipid solubility, molecular loj, thiab particle loj, muaj feem xyuam rau lub ntsws nqus. Cov tshuaj uas muaj lipid solubility ntau dua yuav nkag mus rau lipid daim nyias nyias ntawm alveolar epithelial hlwb, yog li ua kom nrawm nrawm dua. Piv txwv li, liposoluble tshuaj xws li cortisone, hydrocortisone, thiab dexamethasone tau yooj yim nqus los ntawm lipid daim nyias nyias nrog ib nrab ntawm - lub neej ntawm kwv yees li 1.0-1.7 feeb. Cov dej soluble cov tebchaw feem ntau yog nqus los ntawm cov xovtooj ntawm tes, thiab kev nqus tau qeeb dua li cov tshuaj lipophilic, xws li quaternary ammonium ntsev, hippurate ntsev, thiab mannitol, nrog kev nqus ib nrab ntawm lub neej ntawm 45-70 feeb. Qhov loj me me ntawm cov tshuaj kuj tuaj yeem cuam tshuam rau tus nqi nqus, nrog rau cov tshuaj molecule me me absorbing sai thiab cov tshuaj molecule loj absorbing kuj qeeb. Thaum cov txheeb ze molecular loj yog tsawg dua 1000, cov nyhuv ntawm cov txheeb ze molecular loj ntawm tus nqi nqus tsis tseem ceeb. Tsis tas li ntawd, qhov loj ntawm cov tshuaj cuam tshuam ncaj qha cuam tshuam rau lawv qhov chaw tso rau hauv lub ntsws, thiab tswj cov khoom me me ntawm 2-5 microns yog qhov tseem ceeb los xyuas kom meej cov tshuaj muaj txiaj ntsig zoo hauv thaj av alveolar.
Kev tsim cov cuab yeej nqus pa yog qhov tseem ceeb rau kev ua haujlwm ntawm kev xa tshuaj thiab lub ntsws deposition npaum li cas. Tam sim no, cov ntaub ntawv siv tshuaj tshiab thiab kev npaj rau kev tswj lub ntsws feem ntau suav nrog cov tshuaj nqus dej ntau, tshuaj tsuag, tshuaj nqus hmoov qhuav, microspheres thiab liposomes. Kev nqus nqus nqus nqus tau yooj yim siv, txhim khu kev qha thiab ruaj khov, thiab cov tshuaj tsis yooj yim los ntawm cov kab mob. Txawm li cas los xij, muaj teeb meem xws li tsis muaj kev sib koom tes ntawm kev pib- nce thiab nqus pa, thiab qhov sib txawv loj ntawm cov neeg mob. Cov tshuaj tsuag tuaj yeem ua rau cov tshuaj ntau npaum li cas ncav cuag lub ntsws sib sib zog nqus, thiab zam kev tsis sib haum xeeb ntawm cov tshuaj thiab cov tshuaj tiv thaiv, nqus tau thiab pib tsis sib haum thiab lwm yam teeb meem. Qhuav hmoov inhalers yog qhib los ntawm kev ua pa, kov yeej qhov teeb meem ntawm kev tso tshuaj tsis sib haum thiab nqus tau pa, thiab tsim nyog rau ntau yam tshuaj, suav nrog biomolecules xws li cov protein thiab peptides. Cov cuab yeej nqus pa sib txawv muaj cov yam ntxwv sib txawv thiab siv tau, thiab xaiv cov cuab yeej nqus pa uas tsim nyog tuaj yeem txhim kho lub ntsws nqus ntawm cov tshuaj.
Tus neeg mob qhov ntim ua pa, tus nqi ua pa, thiab hom muaj feem cuam tshuam nrog qhov chaw ntawm aerosol hais txog lub ntsws. Feem ntau hais lus, tus nqi ntawm cov tshuaj uas nkag mus rau hauv txoj hlab pa yog proportional rau tus pa pa thiab inversely proportional rau tus pa pa. Kev nqus tau sai thiab nrawm tuaj yeem ua rau lub zog ntawm cov khoom siv tshuaj, ua rau lawv tuaj yeem tso rau hauv cov hlab ntsws ntawm txoj hlab ntsws thiab txo cov tshuaj mus txog alveoli; Thiab kev nqus pa nyias thiab ntev tuaj yeem tso cai rau cov tshuaj mus txog qhov tob ntawm lub ntsws xws li alveoli. Kev ua pa luv luv tuav ntawm ob lub pa tuaj yeem ncua kev tso tawm ntawm cov tshuaj. Qee lub sij hawm, txhawm rau ua kom tau txais txiaj ntsig zoo tshaj plaws ntawm lub ntsws, nws yog ib qho uas yuav tsum tuav ua pa li 5-10 vib nas this tom qab nqus cov tshuaj. Yog li ntawd, kev taw qhia cov neeg mob txog cov qauv ua pa kom raug yog qhov tseem ceeb rau kev txhim kho lub ntsws nqus cov nyhuv ntawm cov tshuaj.
Tus nqi txwv cov txheej txheem thiab kev ua kom zoo rau lub ntsws nqus ntawm Tirzepatide Spray
Ceev txwv cov kauj ruam: Kev tso tawm ntawm cov tshuaj hauv lub ntsws yog ib kauj ruam tseem ceeb hauv lub ntsws nqus, tab sis nws cuam tshuam los ntawm ntau yam xws li particle loj thiab nqus pa tawm nrawm. Cov tshuaj loj dua tuaj yeem ua rau muaj qhov tso tawm hauv lub ntsws sab saud, thaum cov khoom me me tuaj yeem raug tshem tawm los ntawm exhalation, ua rau txo qis ntawm cov tshuaj hauv lub ntsws.
Optimization lub tswv yim: Los ntawm optimizing tus tsim ntawm lub tshuab nqus tsev twj thiab tswj qhov luaj li cas ntawm cov tshuaj mus rau 2-5 microns, lub deposition tus nqi ntawm cov tshuaj nyob rau hauv lub alveolar cheeb tsam yuav tsum tau txhim kho. Piv txwv li, kev siv cov tshuab micronization thiab cov cuab yeej siv tshuaj tshiab tuaj yeem ua rau cov khoom siv tshuaj mus cuag lub hom phiaj kom raug. Nyob rau tib lub sijhawm, kev coj tus neeg mob txog kev ua pa kom raug, siv kev tshoov siab thiab ntev ntev thiab ua pa kom tsim nyog, kuj tseem tuaj yeem pab txhim kho cov kab mob pulmonary deposition ntawm cov tshuaj.
Barrier nyhuv ntawm mucus txheej
Ceev txwv cov kauj ruam: Cov mucous txheej ntawm cov kab mob ua pa yog ib qho ntawm cov teeb meem rau kev nqus tshuaj, thiab nws cov viscosity thiab muaj pes tsawg leeg tuaj yeem cuam tshuam rau tus nqi ntawm cov tshuaj. Cov tshuaj yuav tsum tau kov yeej qhov teeb meem ntawm cov mucus txheej kom ncav cuag lub alveolar epithelial hlwb. Rau qee cov tshuaj uas muaj viscosity muaj zog, qhov kev sib cais ntawm cov hnoos qeev yog qeeb, uas tuaj yeem txo qhov nqus ntawm cov tshuaj.
Optimization lub tswv yim: Ntxiv cov khoom tsim nyog haum, xws li surfactants, mucus solubilizers, thiab lwm yam, rau cov tshuaj formulations yuav txo tau cov viscosity ntawm cov mucus txheej thiab txhawb cov tshuaj dissolution thiab nkag mus. Piv txwv li, qhov sib ntxiv ntawm cov enamine derivative phenylaniline ethyl acetoacetate tuaj yeem txhim kho qhov nqus ntawm insulin hauv qhov quav, thiab cov ntsiab lus zoo sib xws kuj tuaj yeem siv rau kev tswj xyuas pulmonary. Tsis tas li ntawd, optimizing lub physicochemical thaj chaw ntawm cov tshuaj thiab txhim kho lawv lipid solubility kuj pab mus rau lub dissolution thiab nqus cov tshuaj nyob rau hauv cov hnoos qeev.
Kev sib txuas ceev ceev: Cov kev sib txuas nruj ntawm alveolar epithelial hlwb yog ib qho ntawm cov teeb meem tseem ceeb rau kev nqus cov protein thiab peptide tshuaj. Cov kev sib txuas nruj no txwv tsis pub dhau ntawm cov tshuaj molecule loj, ua rau lawv nkag mus rau hauv cov hlab ntsha nyuaj.
Optimization lub tswv yim: Kev siv cov tshuaj tshiab tshiab xws li liposomes thiab microspheres tuaj yeem tiv thaiv cov tshuaj los ntawm kev ua kom cov enzyme degradation thiab bypass nruj junctions los ntawm cell phagocytosis los yog cell bypass thauj, yog li txhim kho kev nqus tshuaj. Piv txwv li, insulin liposomes tuaj yeem ua rau txo qis kev nqus ntawm insulin mus rau hauv cov kab mob hauv lub ntsws, ua kom cov tshuaj insulin los ntawm lub ntsws, thiab ua kom nws cov nyhuv hypoglycemic. Tsis tas li ntawd, kev hloov kho tshuaj los ntawm cov txheej txheem genetic engineering los hloov kho lawv cov qauv molecular kuj tseem tuaj yeem pab txhim kho lawv lub peev xwm los nkag mus rau kev sib txuas ntawm cov cell.
Enzyme Metabolism
Ceev txwv cov kauj ruam: Muaj ntau yam metabolic enzymes nyob rau hauv lub pa mucosa, xws li phosphatase thiab peptidase. Cov tshuaj yuav raug tshem tawm lossis metabolized nyob rau hauv cov ntaub so ntswg epithelial ntawm lub ntsws, ua rau poob ntawm kev ua haujlwm. Kev sim tau pom tias serotonin, norepinephrine, prostaglandin E2, adenosine triphosphate, bradykinin, thiab lwm yam tshuaj tuaj yeem ua rau tag nrho cov metabolized hauv lub ntsws. Enzyme metabolism kuj yog ib qho ntawm cov teeb meem cuam tshuam rau kev nqus tshuaj hauv lub ntsws.
Optimization lub tswv yim: Ntxiv protease inhibitors rau cov tshuaj formulations yuav inhibit enzyme kev ua si, txo cov tshuaj metabolism thiab degradation, thiab txhim kho cov tshuaj bioavailability. Piv txwv li, kev siv ua ke nrog cov tshuaj tiv thaiv protease yog ib txoj hauv kev zoo los txhim kho kev nqus ntawm insulin hauv lub ntsws. Tsis tas li ntawd, optimizing cov qauv tshuaj ntawm cov tshuaj thiab txhim kho lawv kev ruaj ntseg tiv thaiv enzymes kuj tuaj yeem pab txo cov tshuaj metabolism hauv lub ntsws.
Cim npe nrov: Tuam Tshoj tirzepatide spray manufacturers, lwm tus neeg
